(Circulation. 1999;100:768-771.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Division of Cardiology, Department of Medicine, National Yang-Ming University, School of Medicine, and Veterans General Hospital-Taipei and Division of Cardiology, Department of Medicine, Chung Shan Medical and Dental College Hospital (C.-F.T.), Taiwan, R.O.C.
Correspondence to Shih-Ann Chen, MD, Division of Cardiology, Veterans General Hospital-Taipei, 201, Sec 2, Shih-Pai Road, Taipei, Taiwan, R.O.C. E-mail sachen{at}vghtpe.gov.tw
| Abstract |
|---|
|
|
|---|
Methods and ResultsA total of 104 consecutive patients with typical atrial flutter were randomly assigned to undergo radiofrequency linear ablation using a 4- (Group I, n=54) or 8-mm tip electrode (Group II, n=50) catheter (temperature-control model, preset 70°C). If complete bidirectional isthmus block could not be achieved after 5 pulses, the ablation catheter was changed to the other type; the maximal radiofrequency pulse number was limited to <10 pulses. Complete or incomplete isthmus conduction block was assessed by activation sequence in a multielectrode Halo catheter during low lateral right atrial and proximal coronary sinus pacing. Before shifting to the other catheter type, the 8-mm electrode catheter achieved higher complete isthmus block rate (92% versus 67%, P<0.05) with fewer pulses (2±1 versus 3±1, P<0.05), shorter procedure time (24±15 versus 31±12 minutes, P<0.05), and shorter fluoroscopic time (14±10 versus 23±15 minutes, P<0.05). After 5 failed ablation pulses, 12 (67%) of 18 patients in group I attained complete isthmus block by using an 8-mm tip catheter, but none of 4 patients in group II achieved complete block by changing to a 4-mm tip catheter.
ConclusionsThe 8-mm tip electrodes are more effective than the standard 4-mm length electrodes in linear ablation for typical atrial flutter. This clinical benefit may be of particular value for some patients with broad and/or thick isthmus.
Key Words: atrial flutter ablation isthmus
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Radiofrequency Ablation
The methods of electrophysiological
studies and ablation of AF in this laboratory have been described
previously.6 9 All clinically documented AF was induced by
programmed stimulation protocols established in most
laboratories.3 4 5 6 7 8
In all patients, a deflectable duodecapolar Halo catheter
(Cordis-Webster, Inc) was used to demonstrate an AF exhibiting either a
counterclockwise or a clockwise activation around the tricuspid annulus
and through the low right atrium isthmus. All electrograms, filtered
between 30 and 500 Hz, were recorded with a commercial digital
acquisition system (Prucka Engineering, Inc). All patients were
randomly assigned to undergo transisthmus linear ablation using a 4-
(Group I, n=54) or an 8-mm tip electrode (Group II, n=50) catheter
initially. The clinical characteristics were similar between both
groups (Table 1
). RF energy was delivered
by a generator (EPT-1000, EP Technologies, Inc), using a thermistor
ablation catheter with a 4- or 8-mm tip electrode (7F, EP Technologies,
Inc), to achieve a tip-tissue interface temperature of 70°C and an
output of up to 100 W during AF or sinus rhythm (with pacing from the
proximal coronary sinus if AF was not induced). The preset
duration of each RF pulse was 120 seconds. By utilizing a special long
venous sheath (SR0 curve, Daig) to increase stability, continuous
application of RF energy during pull-back of the ablation catheter from
the right ventricle toward the inferior vena cava was used
to create linear lesions in the cavotricuspid isthmus. The 8-mm tip
electrode catheter was not used for linear ablation of medial (septal)
isthmus in close proximity to right posteroseptal area to
avoid the potential risk of atrioventricular block. If
complete isthmus conduction block could not be achieved after 5 pulses,
the ablation catheter was replaced with the other type (Group IA: 4-mm
tip electrode with successful ablation within 5 RF pulses; Group IB:
4-mm
8-mm tip electrode; Group IIA: 8-mm tip electrode with
successful ablation within 5 RF pulses; Group IIB: 8-mm
4-mm tip
electrodes). For comparison of group I and group II, a maximal RF pulse
number was limited to 10 pulses. Successful ablation was defined as
achievement of bidirectional isthmus conduction block and inability to
reinduce typical AF. Complete isthmus conduction block was defined as
low lateral right atrium pacing demonstrating counterclockwise
conduction to the point of block followed by the delayed arrival of
septal activation up to the line of block from the opposite direction;
the similar activation pattern in opposite direction was demonstrated
with proximal coronary sinus pacing.7 9 Incomplete
isthmus conduction block was defined as existence of any residual
isthmus conduction when pacing from either side of the line of block in
the cavotricuspid isthmus, irrespective of reinducibility of AF.
|
Post-Ablation Follow-Up
All patients received 24-hour Holter monitoring 1 day before
hospital discharge. Follow-up examination was performed at 2 weeks, 1
month, and 3 months after ablation with complete history taken,
physical examination, and a 12-lead ECG. When patients experienced
symptoms suggestive of tachycardia, 24-hour Holter
monitoring, cardiac events recording, or a follow-up
electrophysiological study was performed to
define the cause of tachycardia. RF ablation was repeated
if recurrent typical AF was documented. Long-term follow-up information
was also obtained from the referring physicians and through telephone
interviews with the patients.
Statistical Analysis
Quantitative data were expressed as mean±SD and compared by
Student's t test. Categorical data were analyzed by
the
2 test with Yates' correction or
Fisher's exact test. P<0.05 was considered statistically
significant.
| Results |
|---|
|
|
|---|
|
Follow-Up
During a mean follow-up of 10±5 months (range, 6 to 15 months),
patients with incomplete isthmus block had a significantly higher
incidence of recurrent AF than those with complete isthmus block (5 of
10 versus 0 of 94, P<0.0001). In all 5 patients with
recurrent AF, repeated electrophysiological
study revealed recovery of intact isthmus conduction: 1 received
amiodarone therapy and the other 4 underwent a second
successful ablation session. The incidence of clinically documented
atrial fibrillation at follow-up periods was 22% (23 of 104) and was
not significantly different in both groups. This finding suggested that
the occurrence of atrial fibrillation may not be related to the
ablation-induced lesions.
| Discussion |
|---|
|
|
|---|
Effects of a Large Tip Electrode on Radiofrequency Lesion
Previous experimental studies have shown that increase in ablation
electrode size can allow the application of higher RF power, resulting
in a further increase in lesion size and depth.10 11 12
McRury et al demonstrated good correlation between electrode size and
temperature with lesion size in temperature-controlled RF ablation
model in canine ventricles.12 Langberg et al also showed
that the larger electrode could couple higher power and less impedance
rise to achieve the preset target temperature.11 In this
study, the superiority of the 8-mm tip electrode might rely on a larger
and deeper lesion created by 2 mechanisms.13 First, a
larger tip electrode with a larger electrode-blood interface area, in
particular under high blood flow in the cavotricuspid isthmus area,
could increase the convective cooling effect and allow higher RF power
delivery to the tissues at the same electrode-tissue interface
temperature with resulting greater depth of direct resistive heating.
Secondly, increasing electrode-tissue interface area by orienting the
electrode as parallel to the tissue as possible during the dragging
ablation technique could produce greater width of direct resistive
heating. Thus, both increased cooling and increased electrode-tissue
interface area with a large tip electrode increase volume of direct
resistive heating and create a larger and deeper lesion. Langberg et al
showed that thermistor-equipped elongated ablation electrodes (8-mm)
coupled to high-power outputs could reproducibly produce lesions
approximately 1 cm in diameter and 11 mm in depth.11
In this study, we used a temperature feedback power control (up to 100
W) at a target temperature of 70°C. Accordingly, the 8-mm tip
electrode catheter is superior to the 4-mm tip catheter with respect to
energy delivery parameters for a steady-state temperature
to make a larger and deeper lesion.
Some AF cases demonstrating resistance to or difficulty with RF ablation may be due to a broader or thicker than usual isthmus or to complex isthmus architecture with resulting in adaptation of catheters. Tabuchi et al studied isthmus pathology after RF ablation for the canine AF and demonstrated the requirement of transmural damage of the atrial myocardium from the endocardium to the subepicardium for successful isthmus ablation.14 Therefore, using an 8-mm tip electrode catheter (supported by a long vascular sheath for a consistent good contact with endocardial surface and for making continuous lesions during steadily dragging catheter) might be of particular benefit in linear ablation of broad and/or thickened isthmus by producing adequate lesion size and depth to reduce the possibility of skip lesions (gaps) formation.
Comparison With Previous Studies
Feld et al used the
electrophysiological approach for AF
ablation and compared the efficacy between 8- and 4-mm tip catheter.
They showed reductions of the mean number of energy applications (from
11 to 6 pulses) and recurrence rate (from 43% to 10%) by
using 8-mm tip electrode catheters.15 Iesaka et al used
the anatomical approach for ablation of AF by using an 8-mm tip
electrode and used the electrophysiological
approach for ablation of AF by using a 4-mm tip electrode. They also
concluded that the 8-mm tip electrode reduced the number of energy
applications (from 10 to 2.3 pulses) required for successful
ablation.16 In these 2 studies, there were some
confounding issues on validity of results with regard to different
ablation approach methods (anatomic versus electrophysiolgical
approach) and ablation end points (termination and noninducibility
versus isthmus conduction block). Additionally, these studies were not
randomized controlled studies. Our laboratory had reported that the
anatomic approach was time-saving with respect to the procedure time
and radiation exposure time compared with
electrophysiologically guided focal
ablation.6 Additionally, this study used a randomized
prospective method to compare the efficacy of different electrode tip
sizes on ablation of AF by the anatomical approach. Thus, this study
adds further insight into the superiority of 8-mm tip electrode to 4-mm
tip electrode for transisthmus linear ablation of typical AF.
Clinical Implications
This study's results established clearly that 8-mm tip electrodes
are more effective and as safe as the standard 4-mm length electrodes
in transisthmus linear ablation for typical AF. This clinical benefit
of the 8-mm tip catheter for AF ablation may be of particular value for
some patients with broad and/or thick isthmus.
| Acknowledgments |
|---|
Received January 19, 1999; revision received April 9, 1999; accepted April 15, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. E. Eckart and L. M. Epstein Interventional Therapy for Atrial and Ventricular Arrhythmias Card. Surg. Adult, January 1, 2008; 3(2008): 1357 - 1374. [Full Text] |
||||
![]() |
J. E. Marine Catheter Ablation Therapy for Supraventricular Arrhythmias JAMA, December 19, 2007; 298(23): 2768 - 2778. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF] |
||||
![]() |
F G Cosio Should ablation be the first line treatment for supraventricular arrhythmias? Heart, January 1, 2005; 91(1): 5 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hillock, I. C. Melton, and I. G. Crozier Radiofrequency ablation for common atrial flutter using an 8-mm tip catheter and up to 150 W Europace, January 1, 2005; 7(5): 409 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Da Costa, E. Faure, J. Thevenin, M. Messier, S. Bernard, K. Abdel, C. Robin, C. Romeyer, and K. Isaaz Effect of Isthmus Anatomy and Ablation Catheter on Radiofrequency Catheter Ablation of the Cavotricuspid Isthmus Circulation, August 31, 2004; 110(9): 1030 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scavee, P. Jais, L.-F. Hsu, P. Sanders, M. Hocini, R. Weerasooriya, L. Macle, F. Raybaud, J. Clementy, and M. Haissaguerre Prospective randomised comparison of irrigated-tip and large-tip catheter ablation of cavotricuspid isthmus-dependent atrial flutter Eur. Heart J., June 1, 2004; 25(11): 963 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Feld, M. Wharton, V. Plumb, E. Daoud, T. Friehling, L. Epstein, and EPT-1000 XP Cardiac Ablation System Investigators Radiofrequency catheter ablation of type 1 atrial flutter using large-tip 8- or 10-mm electrode catheters and a high-output radiofrequency energy generator: Results of a multicenter safety and efficacy study J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1466 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Satti and L. M. Epstein Cardiologic Interventional Therapy for Atrial and Ventricular Arrhythmias Card. Surg. Adult, January 1, 2003; 2(2003): 1253 - 1270. [Full Text] |
||||
![]() |
G. Stabile, A. De Simone, P. Turco, V. La Rocca, P. Nocerino, C. Astarita, F. Maresca, C. De Matteis, T. Di Napoli, E. Stabile, et al. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1639 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kottkamp, B. Hugl, B. Krauss, U. Wetzel, A. Fleck, G. Schuler, and G. Hindricks Electromagnetic Versus Fluoroscopic Mapping of the Inferior Isthmus for Ablation of Typical Atrial Flutter : A Prospective Randomized Study Circulation, October 24, 2000; 102(17): 2082 - 2086. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |